Introduction – The Changing Standard of Care for Enlarged Prostate
Benign prostatic hyperplasia (BPH) — or enlarged prostate — affects nearly 50% of men over 50 and 80% of men over 80. When medications fail to control symptoms like frequent urination, weak stream, incomplete bladder emptying, and nocturia, surgical treatment becomes necessary.
For three decades, TURP (Transurethral Resection of the Prostate) was considered the gold standard surgical treatment for BPH. It remains effective and widely practised. However, over the past 15 years, a growing body of evidence — including multiple randomised controlled trials — has established that HoLEP (Holmium Laser Enucleation of the Prostate) delivers superior or equivalent clinical outcomes with a significantly better safety profile, particularly for men with large prostates, bleeding risk, or those on blood thinners.
This article explains both procedures, compares them honestly, and helps you understand which approach your urologist might recommend.
What Is TURP?
TURP stands for Transurethral Resection of the Prostate. A resectoscope (telescope with an electric loop) is passed through the urethra into the prostate. The surgeon uses the electric loop to shave away (resect) the obstructing prostate tissue piece by piece, which is then washed out. The procedure takes 45–90 minutes under spinal or general anaesthesia.
TURP is effective, well-studied, and accessible. Most district-level hospitals in India with urology departments can perform TURP. Its main limitations are:
- TURP syndrome: Absorption of the irrigation fluid into the bloodstream can cause dangerous dilutional hyponatraemia — now less common with bipolar TURP systems using saline irrigation
- Bleeding: Resection of vascular prostate tissue carries meaningful bleeding risk, with transfusion rates of 1–5%
- Retreatment: Tissue regrowth means 15–20% of men need re-treatment within 10 years
- Size limitation: Standard TURP is limited to prostates up to approximately 80 grams; larger prostates traditionally required open surgery
What Is HoLEP (Holmium Laser Enucleation of the Prostate)?
HoLEP uses a holmium laser fibre passed through a resectoscope to precisely enucleate (shell out) the obstructing adenoma — the enlarged inner portion of the prostate — along the natural anatomical plane between the adenoma and the outer prostatic capsule. The enucleated lobes are pushed into the bladder and then morcellated (shredded into small pieces) by a separate device for removal.
Key advantages of this approach:
- The entire obstructing adenoma is removed — not just shaved — resulting in lower retreatment rates
- The holmium laser coagulates blood vessels precisely as it cuts, resulting in minimal blood loss
- HoLEP can treat prostates of any size — including those over 200 grams — that would previously have required open surgery
- Tissue retrieved from morcellation is sent for pathology, enabling incidental prostate cancer detection in 4–8% of cases
What About GreenLight PVP (Photoselective Vaporisation)?
GreenLight (532 nm laser) vaporises prostate tissue rather than enucleating it. It has a very low bleeding risk and can often be performed as day surgery. However, it does not retrieve tissue for pathology, has lower durability for very large prostates, and higher retreatment rates compared to HoLEP. GreenLight is a reasonable option for men with smaller prostates (<80 g), significant anaesthetic risk, or who are on mandatory anticoagulation and need the absolute minimum bleeding risk procedure.
Head-to-Head Comparison: HoLEP vs TURP
| Parameter | TURP (Bipolar) | HoLEP (Holmium Laser) |
|---|---|---|
| Principle | Electric loop shaves tissue piecemeal | Laser enucleates the entire adenoma en bloc |
| Blood loss | Moderate; transfusion in 1–5% | Minimal; transfusion <0.5% |
| Safe for patients on blood thinners | No — thinners usually stopped 5–7 days pre-op | Yes — can be performed without stopping anticoagulants |
| TURP syndrome risk | Present (monopolar); eliminated with bipolar saline | None (saline irrigation throughout) |
| Prostate size limit | Best for prostates <80 g | No size limit — treats 30 g to 300+ g prostates |
| Tissue for pathology | Yes (resected chips sent) | Yes (morcellated tissue sent — larger volume) |
| Catheter duration post-op | 2–5 days | 1–2 days |
| Hospital stay | 2–4 days | 1–2 days |
| Symptom relief (IPSS improvement) | Excellent | Equivalent or slightly superior |
| Urinary flow improvement | Excellent | Equivalent or slightly superior |
| Retreatment rate (10-year) | 15–20% | 1–5% |
| Retrograde ejaculation | 65–90% | 75–90% (similar) |
| Urinary incontinence (transient) | 5–10% (temporary) | 10–20% (temporary, longer recovery; rare permanent) |
| Approximate cost (Medanta Lucknow) | ₹60,000 – ₹90,000 | ₹90,000 – ₹1,30,000 |
| Surgeon learning curve | 30–50 cases | 50–75 cases (steeper, specialised training needed) |
Who Still Needs TURP Today?
TURP is not obsolete. It remains the appropriate choice in several situations:
- Hospitals where HoLEP equipment or trained surgeons are not available
- Prostates in the 30–60 gram range where both procedures work equally well and TURP is more accessible or affordable
- Patients with specific anatomical variations where enucleation is technically difficult
- Situations where cost is the primary constraint and bipolar TURP is available at significantly lower cost
Bipolar TURP (using saline irrigation instead of glycine solution) has eliminated TURP syndrome and remains a safe, effective procedure with good short and medium-term outcomes.
Ideal Candidates for HoLEP
HoLEP is the preferred option for:
- Men with large prostates (>80 grams) — previously requiring open prostatectomy
- Men on anticoagulants (warfarin, rivaroxaban, apixaban, clopidogrel) who cannot safely stop medication
- Men with urinary retention requiring complete adenoma removal for reliable voiding
- Younger men who want the lowest possible retreatment rate
- Men with a PSA elevation where the surgical specimen can help exclude or diagnose cancer
- Men who have had prior pelvic radiation or other complex pelvic histories
Dr Manmeet Singh's Recommendation
At Medanta Lucknow, HoLEP is my preferred surgical treatment for BPH in patients who require intervention. The evidence supporting HoLEP is now so robust — across multiple randomised trials and meta-analyses — that it has been adopted as the first-line surgical recommendation by the European Association of Urology (EAU) guidelines for prostates of any size.
The temporary urinary leakage that some patients experience in the first few weeks after HoLEP is the most common concern patients raise. I address this with pre-operative pelvic floor training and post-operative bladder retraining — and reassure patients that in nearly all cases, continence is fully restored within 6–12 weeks.
For patients with small prostates (<50 g), mild symptoms, or situations where HoLEP expertise is unavailable, bipolar TURP remains an excellent, time-tested option.
Medical Disclaimer: This article is for educational purposes only. Consult Dr Manmeet Singh or a qualified urologist for personalized medical advice.
Frequently Asked Questions
Will I lose erectile function after HoLEP or TURP?
Neither HoLEP nor TURP directly damages the nerves responsible for erections — these run outside the prostate capsule and are not disturbed during either procedure. Both procedures cause retrograde ejaculation (dry orgasm) in the majority of patients, which is a permanent change but not the same as erectile dysfunction. Erectile function is generally preserved.
How long does temporary urinary leakage last after HoLEP?
Most patients experience some degree of stress urinary leakage (dripping on coughing or movement) for 2–8 weeks after HoLEP as the sphincter adjusts to the absence of the adenoma. Pelvic floor exercises resolve this in most patients within 6–12 weeks. Permanent incontinence is rare (<1%) in experienced hands.
Can HoLEP cure very large prostates that were previously treated with open surgery?
Yes. This is one of HoLEP's most significant advantages. Prostates of 200, 300, even 400 grams that would previously have required a major open operation (open transvesical prostatectomy) can now be treated through the urethra with HoLEP, with minimal blood loss and a hospital stay of 1–2 days.
Does TURP or HoLEP increase the risk of prostate cancer?
Neither procedure causes prostate cancer. Both remove the benign inner adenoma tissue — not the entire prostate gland. A portion of the prostate (the peripheral zone where most cancers arise) remains. PSA monitoring should continue after both procedures, typically at a lower level than before surgery.
Is HoLEP available on insurance or PMJAY in India?
Most health insurance policies in India cover HoLEP as a BPH surgical procedure. Ayushman Bharat PMJAY covers TURP-equivalent procedures and increasingly covers HoLEP at empanelled hospitals. Confirm the specific procedure code coverage with your insurer or the hospital billing team before surgery.
How does the cost of HoLEP at Medanta Lucknow compare to TURP?
HoLEP costs approximately ₹30,000–40,000 more than bipolar TURP at Medanta Lucknow due to the specialised laser equipment and morcellator used. However, when you factor in lower retreatment rates over 10 years, fewer repeat hospitalisations, and significantly shorter catheter time, HoLEP often proves more cost-effective overall.